Godavari Drugs Denies Undisclosed Price Sensitive Information

Godavari Drugs responds to BSE inquiry regarding significant recent share price movement across exchanges.
Company confirms full compliance with SEBI Listing Regulations, making all required timely disclosures.
Firm states it is unaware of any undisclosed price-sensitive information requiring intimation to exchanges.
Attributes share price movement entirely to market conditions beyond company control.